Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3UBD

Structure of N-terminal domain of RSK2 kinase in complex with flavonoid glycoside SL0101

3UBD の概要
エントリーDOI10.2210/pdb3ubd/pdb
分子名称Ribosomal protein S6 kinase alpha-3, 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl 3,4-di-O-acetyl-6-deoxy-alpha-L-mannopyranoside (3 entities in total)
機能のキーワードkinase-inhibitor complex, induced fit, transferase-transferase inhibitor complex, transferase/transferase inhibitor
由来する生物種Mus musculus (mouse)
細胞内の位置Nucleus : P18654
タンパク質・核酸の鎖数1
化学式量合計35516.21
構造登録者
Utepbergenov, D.,Derewenda, U.,Derewenda, Z.S. (登録日: 2011-10-24, 公開日: 2012-09-05, 最終更新日: 2023-09-13)
主引用文献Utepbergenov, D.,Derewenda, U.,Olekhnovich, N.,Szukalska, G.,Banerjee, B.,Hilinski, M.K.,Lannigan, D.A.,Stukenberg, P.T.,Derewenda, Z.S.
Insights into the Inhibition of the p90 Ribosomal S6 Kinase (RSK) by the Flavonol Glycoside SL0101 from the 1.5 A Crystal Structure of the N-Terminal Domain of RSK2 with Bound Inhibitor.
Biochemistry, 51:6499-6510, 2012
Cited by
PubMed Abstract: The p90 ribosomal S6 family of kinases (RSK) are potential drug targets, due to their involvement in cancer and other pathologies. There are currently only two known selective inhibitors of RSK, but the basis for selectivity is not known. One of these inhibitors is a naturally occurring kaempferol-α-L-diacetylrhamnoside, SL0101. Here, we report the crystal structure of the complex of the N-terminal kinase domain of the RSK2 isoform with SL0101 at 1.5 Å resolution. The refined atomic model reveals unprecedented structural reorganization of the protein moiety, as compared to the nucleotide-bound form. The entire N-lobe, the hinge region, and the αD-helix undergo dramatic conformational changes resulting in a rearrangement of the nucleotide binding site with concomitant formation of a highly hydrophobic pocket spatially suited to accommodate SL0101. These unexpected results will be invaluable in further optimization of the SL0101 scaffold as a promising lead for a novel class of kinase inhibitors.
PubMed: 22846040
DOI: 10.1021/bi300620c
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.53 Å)
構造検証レポート
Validation report summary of 3ubd
検証レポート(詳細版)ダウンロードをダウンロード

251801

件を2026-04-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon